VOLUNTARY DISSOLUTION - LIQUIDATION

Foodchain ID Genomics

Company — Voluntary dissolution - liquidation.

Financial year 2025 · Closed on 31/12/2025

Net result-2,8 k €-106,9 %over 1 year
Gross margin-329 €-100,6 %over 1 year
Equity-511,9 k €-0,6 %over 1 year

Identity

Source · BCE/KBO

Foodchain ID Genomics is a Public limited company incorporated in 2015. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Herstal.

Legal situation
Voluntary dissolution - liquidation
BCE/KBO no. / VAT
BE 0628.865.351
Incorporation
24/04/2015
Legal form
Public limited company
Registered office
En Hayeneux 62
4040 Herstal · WallonieSee on map
Contributed capital
185 512,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 207

Financials

Source · NBB, 14 filings

Trend over 12 financial years

20252024202420232022
Income statement
Gross margin-329 €50,9 k €11,7 k €––
EBITDA-11,1 k €50,8 k €-89,8 k €-94,4 k €73,7 k €
Operating result-1,7 k €41,5 k €-14,1 k €-256,7 k €24,5 k €
Net result-2,8 k €40,6 k €-15 k €-259,5 k €23,3 k €
Balance sheet
Equity-511,9 k €-509,1 k €-549,7 k €-534,7 k €-275,2 k €
Total assets143,7 k €143,1 k €194,7 k €231,8 k €428,2 k €
Cash2,7 k €396 €15,5 k €22,5 k €21,4 k €
Debts655,6 k €652,2 k €744,4 k €690,8 k €703,4 k €
Other
Workforce–––2,5 ETP2,7 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 41 ended

Active mandates

AETIC CONSULTING SAS

Mandate

Represented by Nicolas GROS

Active

Ended mandates

AETIC Consulting SAS

Managing director · since 11 janvier 2021

Represented by Nicolas GROS

Ended
Chetan PARMAR

Director · since 02 janvier 2020 · until 11 juin 2024

Ended
Parma Chetan

Director · since 02 janvier 2020 · until 11 juin 2020

Ended
Brad RIEMENAPP

Director · since 28 juin 2018 · until 13 juin 2024

Ended

Other companies at this address

En Hayeneux 62 4040 Herstal
CompanyCBE no.
0679.546.366
0470.109.411

Full financial information

Source · NBB
202520242024202320222021
Type of accountAbridged modelAbridged modelAbridged modelFull modelFull modelFull model
Start of the financial year01/01/202527/03/202401/01/202401/01/202301/01/202201/01/2021
Closing of the financial year31/12/202531/12/202426/03/202431/12/202331/12/202231/12/2021
Length of the financial year12 months10 months3 months12 months12 months12 months
Filing date15/06/202616/06/202616/06/202620/06/202419/07/202313/07/2022
General meeting11/06/202611/06/202611/06/202626/03/202429/06/202330/06/2022
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202511/06/202615/06/2026FrenchPDF
Abridged model31/12/202411/06/202616/06/2026FrenchPDF
Full model31/12/202419/06/202503/07/2025FrenchPDF
Abridged model26/03/202411/06/202616/06/2026FrenchPDF
Full model31/12/202326/03/202420/06/2024FrenchPDF
Full model31/12/202229/06/202319/07/2023FrenchPDF
Full model31/12/202130/06/202213/07/2022FrenchPDF
Full model31/12/202025/06/202128/06/2021FrenchPDF
Full model31/12/201916/07/202017/07/2020FrenchPDF
Abridged modelCorrection31/12/201813/06/201916/10/2019FrenchPDF
Abridged model31/12/201813/06/201918/06/2019FrenchPDF
Micro model31/12/201707/06/201803/07/2018FrenchPDF
Micro model31/12/201608/05/201706/06/2017FrenchPDF
Abridged model31/12/201502/06/201614/06/2016FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 41 ended

Active mandates

AETIC CONSULTING SAS

Mandate

Represented by Nicolas GROS

Active

Ended mandates

AETIC Consulting SAS

Managing director · since 11 janvier 2021

Represented by Nicolas GROS

Ended
Chetan PARMAR

Director · since 02 janvier 2020 · until 11 juin 2024

Ended
Parma Chetan

Director · since 02 janvier 2020 · until 11 juin 2020

Ended
Brad RIEMENAPP

Director · since 28 juin 2018 · until 13 juin 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Court decision10/06/2024
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Mandates16/10/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/02/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DENOMINATION
    PDF
  • Mandates30/03/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/02/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares29/04/2019
    CAPITAL, ACTIONS
    PDF
  • Capital / shares16/10/2018
    CAPITAL, ACTIONS
    PDF
  • Mandates30/07/2018
    DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-2,8 k €↓
  2. 2024
    Annual accounts 202440,6 k €↑
  3. 2024
    Annual accounts 2024-15 k €↑
  4. 2024
    Name changeFoodchain ID Genomics en liquidation
  5. 2023
    Annual accounts 2023-259,5 k €↓
  6. 2022
    Annual accounts 202223,3 k €↑
  7. 2022
    Name changeFoodchain ID Genomics
  8. 2021
    Annual accounts 2021-122,4 k €↑
  9. 2020
    Annual accounts 2020-158,4 k €↑
  10. 2019
    Annual accounts 2019-160,8 k €↓
  11. 2018
    Annual accounts 2018-42,6 k €↑
  12. 2017
    Annual accounts 2017-121,4 k €↓
  13. 2016
    Annual accounts 2016-28,7 k €↑
  14. 2015
    Annual accounts 2015-41,8 k €
  15. 24/04/2015
    IncorporationPublic limited company
  16. 2015
    Name changeGENALYSE PARTNER